BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MD Stem Cells Release: Eye Patient Treated With Stem Cells Using New Dual Injection Technique


11/13/2012 2:07:40 PM

November 13, 2012 -- MD Stem Cells is pleased to announce the first treatment in the United States of a patient with eye disease using a new injection technique for Bone Marrow Derived Stem Cells( BMSC). Dr Steven Levy, President of MD Stem Cells www.mdstemcells.com , indicated the procedure went smoothly and that they are anticipating a positive response in the next several months.

“We are quite familiar with the use of BMSC in ophthalmology for both retinal and optic nerve diseases and have observed macular degeneration, myopic degeneration, hereditary retinopathies and glaucoma patients experience visual improvements following treatment. Our retinal surgeon has used both subretinal surgery and different injection techniques in the past for the placement of BMSC in ocular disease. We have collaboratively developed a dual injection technique that we believe takes advantage of the recently identified active vascular expulsion mechanism of cell transmigration and are very excited about our ability to deliver the BMSC to the RPE, retina and optic nerve.”

Dr Levy indicated that while this particular patient had suffered from optic nerve disease, the next patients will include AMD or macular degeneration and myopic degeneration.

“We believe strongly that regenerative medicine is an evolving arena and that there will be room for any number of approaches to stem cell use to benefit patients.”



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES